Cases & Deals

North Coast invests in Cervilenz

Clients North Coast Angel Fund

Jones Day advised North Coast Angel Fund in its purchase of Series A Convertible Preferred Stock in a private placement by CerviLenz Inc., a manufacturer and marketer of a patented, FDA-cleared device to predict preterm birth risk in pregnant women.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.